This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Cytomegalovirus infection, IBD co-morbidity
IBD_CMV
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
729 |
4. Check minimum number of eventsNone |
729 |
5. Include endpoints |
776 |
6. Filter based on genotype QC (FinnGen only) |
776 |
Control definitions (FinnGen only)
- Control exclude
- IBD_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- B25-B34
- Name in latin
- Morbus cytomegaloviralis
Similar endpoints
↥List of similar endpoints to
Cytomegalovirus infection, IBD co-morbidity
based on the number of shared cases.
Similar with more cases:
- Cytomegaloviral disease
- Infections, IBD-co-morbidities
- Other viral diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 776 | 390 | 386 |
| Unadjusted period prevalence (%) | 0.15 | 0.13 | 0.17 |
| Median age at first event (years) | 53.44 | 50.84 | 56.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 705
- Matched controls
- 7048
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
323.0
334
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
+∞
323.0
296
*
127
Kela drug reimbursment
Transplant complication
121.8
309.6
321
48
L04AA06
ATC
mycophenolic acid; systemic
66.8
234.8
268
64
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
21.1
180.2
284
218
L04AD01
ATC
ciclosporin; systemic
52.9
175.9
210
56
Z94.0
ICD-10 Finland
Kidney transplant status
78.2
174.2
194
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
21.7
173.9
270
196
H02AB04
ATC
methylprednisolone; systemic
11.7
159.4
347
537
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
85.0
148.8
164
25
R50.9
ICD-10 Finland
Fever, unspecified
10.3
144.2
338
578
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
43.8
141.8
176
53
TK800
NOMESCO Finland
Hemodialysis
38.3
138.2
177
61
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
67.6
134.8
154
29
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
42.5
133.7
167
51
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.8
128.7
302
498
A11CC03
ATC
alfacalcidol; systemic
34.0
116.1
153
57
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
19.8
115.4
181
121
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
89.9
109.3
120
16
C03CA01
ATC
furosemide; systemic
6.5
103.6
349
925
A12AA04
ATC
calcium carbonate; oral
47.3
100.1
122
31
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.6
98.7
224
326
B03XA02
ATC
darbepoetin alfa; parenteral
34.6
96.4
126
44
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
22.2
95.2
142
79
XW000
NOMESCO Finland
Bone marrow biopsy
15.6
92.7
159
129
Z49.1
ICD-10 Finland
Extracorporeal dialysis
50.5
92.3
111
26
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.4
90.6
385
1291
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
61.1
86.0
100
19
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.9
85.6
473
2057
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
65.9
84.5
97
17
A05AA02
ATC
ursodeoxycholic acid; oral
32.3
82.9
110
40
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.4
80.9
251
561
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
99.1
80.0
87
10
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.3
78.8
167
207
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
12.3
78.4
150
152
M04AA01
ATC
allopurinol; systemic
7.4
77.4
207
374
ZX120
NOMESCO Finland
Intravenous
7.6
75.7
198
345
137
Kela drug reimbursment
Uraemia requiring dialysis
39.0
75.0
95
28
N18.8
ICD-10 Finland
Other chronic renal failure
22.1
74.8
111
59
L04AA01
ATC
[U] ciclosporin; systemic
30.5
74.2
100
38
WW500
NOMESCO Finland
Blood transfusion
13.2
70.1
128
116
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
50.7
67.5
81
18
L04AX01
ATC
azathioprine; systemic
10.9
67.4
136
151
N18.0
ICD-10 Finland
End-stage renal disease
42.0
65.8
82
22
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
27.7
65.2
90
37
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.7
64.8
280
874
R4110
NOMESCO Finland
Physiotherapy
4.3
64.3
320
1144
V03AE01
ATC
polystyrene sulfonate; oral
34.6
63.8
83
27
TPX10
NOMESCO Finland
Implantation of vascular injection port
17.0
63.3
103
70
B05DA
ATC
Isotonic solutions
34.0
60.5
79
26
ZXD05
NOMESCO Finland
Urgent procedure
3.9
60.0
345
1382
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
628.4
59.6
58
*
WW200
NOMESCO Finland
Immunization
14.5
59.3
103
82
L03AA02
ATC
filgrastim; parenteral
16.1
59.0
98
70
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.6
58.5
167
318
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
26.0
57.8
81
35
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
84.9
56.0
62
8
Z2446
NOMESCO Finland
Social worker
7.5
54.7
139
223
ZXE20
NOMESCO Finland
More than three and less than five hours
5.0
54.4
203
529
J01MA12
ATC
levofloxacin; systemic
4.5
54.3
232
694
Z49.0
ICD-10 Finland
Preparatory care for dialysis
39.4
54.0
68
19
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
53.5
319
1283
C08CA01
ATC
amlodipine; oral
3.6
53.3
337
1420
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
11.0
52.0
103
108
Z49.2
ICD-10 Finland
Other dialysis
29.2
51.0
69
26
K77.0*B25.1
ICD-10 Finland
Cytomegaloviral hepatitis
+∞
49.6
47
*
J05AB11
ATC
valaciclovir; oral
4.8
48.8
186
489
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
9.9
48.7
102
118
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
48.4
252
887
TGC00
NOMESCO Finland
Bronchial lavation
13.4
48.2
86
72
B05DB
ATC
Hypertonic solutions
31.3
47.4
63
22
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.8
46.0
244
867
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.5
45.7
105
142
A41.9
ICD-10 Finland
Sepsis, unspecified
11.4
45.6
88
87
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.4
45.0
104
142
V03AE02
ATC
sevelamer; oral
62.2
45.0
52
9
196
Kela drug reimbursment
Paricalcitol and cinacalcet
87.7
44.5
49
6
ZX108
NOMESCO Finland
Inhalation
33.1
44.4
58
19
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
32.5
43.4
57
19
B03XA01
ATC
erythropoietin; parenteral
38.8
42.9
54
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
42.7
292
1247
N17.9
ICD-10 Finland
Acute renal failure, unspecified
10.7
42.7
85
89
H02AB09
ATC
hydrocortisone; systemic
13.6
42.5
75
61
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.0
42.3
199
631
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.9
42.1
204
663
205
Kela drug reimbursment
Chronic hypertension
3.3
39.7
257
1044
JN4BD
NOMESCO Finland
Extensive body CT
4.8
39.6
146
363
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
32.2
38.8
51
17
Z94.4
ICD-10 Finland
Liver transplant status
45.6
38.6
47
11
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.8
38.4
80
91
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
10.9
38.2
75
76
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.4
37.5
122
263
JN4AD
NOMESCO Finland
Body CT examination
5.3
37.3
124
274
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.5
37.1
118
248
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.2
37.1
159
457
ZXE00
NOMESCO Finland
One hour or less
2.8
37.0
364
1934
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
36.8
35
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.3
36.8
122
269
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
30.2
36.0
48
17
A07AA02
ATC
nystatin; oral
6.5
34.5
95
166
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
38.0
34.1
43
12
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
26.4
34.0
47
19
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.7
33.3
367
2042
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
46.9
33.1
40
9
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
33.1
326
1695
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.4
32.8
105
221
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.4
32.6
130
345
5AB14
NOMESCO Finland
NA
75.5
32.2
36
5
H02AB06
ATC
prednisolone; systemic
2.6
32.1
389
2264
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.0
32.0
111
255
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
22.3
31.7
46
22
WX002
NOMESCO Finland
Sedation and analgesia
3.2
31.6
202
790
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
17.3
31.6
50
31
A02BC02
ATC
pantoprazole; systemic
2.7
31.1
507
3459
ZXA00
NOMESCO Finland
Right side
2.8
31.0
253
1163
UJF32
NOMESCO Finland
Coloscopy
2.9
30.9
241
1076
J01MA14
ATC
moxifloxacin; systemic
4.6
30.8
117
295
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.5
30.6
64
73
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.3
30.5
52
39
J01MA02
ATC
ciprofloxacin; systemic
2.6
30.4
335
1830
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
29.9
123
335
GD1AD
NOMESCO Finland
Thorax CT examination
7.0
29.8
76
119
B99
ICD-10 Finland
Other and unspecified infectious diseases
14.5
29.5
50
37
N02AA05
ATC
oxycodone; systemic
3.7
29.4
145
463
Z3226
NOMESCO Finland
Physiotherapist
3.1
29.4
194
769
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
29.4
28
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
26.4
29.1
40
16
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
156.4
28.9
30
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
21.2
28.6
42
21
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
28.4
124
356
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
18.0
28.3
44
26
J05AB01
ATC
aciclovir; systemic
2.9
28.2
203
852
WX892
NOMESCO Finland
Monitored bed care
4.6
28.1
104
255
WX872
NOMESCO Finland
Intensive care
5.9
28.0
82
154
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
28.0
303
1618
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
81.0
28.0
31
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.4
27.9
88
181
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
29.9
27.9
37
13
D70.89
ICD-10 Finland
Neutropenic splenomegaly
22.2
27.7
40
19
H05BX01
ATC
cinacalcet; oral
36.7
27.7
35
10
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.5
27.5
85
171
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
55.7
27.4
32
6
N02AX02
ATC
tramadol; systemic, rectal
2.4
27.3
350
2035
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
22.8
27.2
39
18
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
26.5
112
311
RS220
NOMESCO Finland
NA
13.6
26.5
46
36
C08CA02
ATC
felodipine; oral
4.3
26.1
103
268
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
13.6
26.0
45
35
A02BC01
ATC
omeprazole; systemic
2.6
25.8
242
1183
Z3231
NOMESCO Finland
Registered nurse
2.5
25.8
257
1298
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16.0
25.4
41
27
TK820
NOMESCO Finland
Peritoneal dialysis
24.5
25.0
35
15
J02AC03
ATC
voriconazole; systemic
258.7
24.8
25
*
C07AB07
ATC
bisoprolol; oral
2.3
24.7
348
2087
JN3AD
NOMESCO Finland
Abdominal CT examination
4.1
24.7
102
277
C02AC05
ATC
moxonidine; oral
6.0
24.6
70
127
JJC00
NOMESCO Finland
Allogenic transplantation of liver
35.9
24.5
31
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
24.1
108
315
C07AB02
ATC
metoprolol; systemic
2.9
23.9
172
710
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
27.8
23.7
32
12
Z2221
NOMESCO Finland
Medical doctor
2.5
23.3
241
1226
V03AE03
ATC
lanthanum carbonate; oral
56.0
23.2
27
5
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.1
23.0
75
160
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
13.2
22.9
40
32
H26.3
ICD-10 Finland
Drug-induced cataract
21.6
22.8
33
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
22.6
120
401
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.8
22.5
79
182
A07AA09
ATC
vancomycin; oral
24.9
22.3
31
13
321
Kela drug reimbursment
Paricalcitol and cinacalcet
36.3
22.2
28
8
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
36.3
22.2
28
8
B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
22.0
21
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.1
22.0
50
66
KBV00
NOMESCO Finland
Insertion of stent into ureter
19.2
21.9
33
18
A04AA01
ATC
ondansetron; systemic, rectal
4.4
21.9
84
212
B01AB05
ATC
enoxaparin; parenteral
2.4
21.8
240
1252
AA1AD
NOMESCO Finland
CT of head and brain
2.6
21.6
188
866
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
6.1
21.5
60
106
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
35.0
21.2
27
8
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.2
21.2
52
77
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
6.1
21.2
59
104
J01FF01
ATC
clindamycin; systemic
2.4
21.0
233
1217
B02.9
ICD-10 Finland
Zoster without complication
4.9
20.9
71
158
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
216.0
20.7
21
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
17.6
20.6
32
19
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
20.6
64
129
C07AG02
ATC
carvedilol; oral
4.4
20.4
77
191
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.4
20.4
38
35
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
33.7
20.3
26
8
M05BA04
ATC
alendronic acid; oral
4.4
20.1
75
184
212
Kela drug reimbursment
Gout
10.5
20.1
39
39
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.9
20.0
87
246
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
20.0
401
2718
B01AB10
ATC
tinzaparin; parenteral
4.1
19.9
82
221
B25.1
ICD-10 Finland
Cytomegaloviral hepatitis
+∞
19.9
19
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
10.3
19.8
39
40
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
41.4
19.6
24
6
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.4
19.5
43
54
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.8
19.4
66
147
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.5
19.3
186
899
C09AA02
ATC
enalapril; systemic
2.5
19.1
169
778
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.6
19.1
45
63
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.1
19.0
77
204
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
56.6
19.0
22
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
10.8
18.8
36
35
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.7
18.8
66
152
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.8
18.8
54
99
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
18.8
150
651
H3603, E103
ICD-10 Finland
NA
12.8
18.8
33
27
C90.0
ICD-10 Finland
Multiple myeloma
15.6
18.6
30
20
M10.9
ICD-10 Finland
Gout, unspecified
4.5
18.2
67
162
K51.5
ICD-10 Finland
Left sided colitis
6.0
18.2
51
91
R4190
NOMESCO Finland
Nutritional therapy
5.4
18.1
55
108
B34.9
ICD-10 Finland
Viral infection, unspecified
6.5
18.1
47
76
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
18.0
183
904
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.9
18.0
78
220
H43.1
ICD-10 Finland
Vitreous haemorrhage
7.6
18.0
42
58
TK810
NOMESCO Finland
Hemofiltration
14.2
17.9
30
22
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
17.7
97
327
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
97.5
17.6
19
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.7
17.6
61
139
A41.8
ICD-10 Finland
Other specified sepsis
10.4
17.6
34
34
121
Kela drug reimbursment
Severe hypofunction of sexual glands
8.2
17.5
39
50
N17.8
ICD-10 Finland
Other acute renal failure
12.4
17.5
31
26
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
6.4
17.4
46
76
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.8
17.4
37
44
6BA02
NOMESCO Finland
NA
43.1
17.4
21
5
Z94.1
ICD-10 Finland
Heart transplant status
32.4
17.1
22
7
Z94.2
ICD-10 Finland
Lung transplant status
51.3
17.1
20
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.6
16.8
60
141
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
16.8
112
435
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.2
16.7
37
47
0785B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[HEPATITIS CYTOMEGALICA]
+∞
16.7
16
*
N19
ICD-10 Finland
Unspecified kidney failure
6.6
16.6
43
69
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
92.3
16.6
18
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.8
16.6
33
35
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
173.9
16.6
17
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
15.8
16.3
26
17
ZXA05
NOMESCO Finland
Left side
2.2
16.2
204
1107
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
30.8
16.2
21
7
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
17.2
16.2
25
15
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
12.0
16.2
29
25
SPAT1255
SPAT
Intravenous administration of medicine
3.7
16.1
74
219
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
19.1
16.1
24
13
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
12.6
16.0
28
23
SPAT1262
SPAT
Handing over of treatment supplies
2.4
16.0
153
729
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
15.9
465
5641
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
14.9
15.9
26
18
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
11.6
15.9
29
26
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
61.4
15.8
18
*
C02CA01
ATC
prazosin; oral
10.1
15.8
31
32
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
34.2
15.8
20
6
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8.1
15.7
35
45
WW300
NOMESCO Finland
Transfer of autologic stem cells
17.7
15.7
24
14
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
6.4
15.7
41
67
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
163.4
15.5
16
*
WW400
NOMESCO Finland
Plasmaferesis
163.4
15.5
16
*
U14
ICPC
Kidney symptom/complaint
12.7
15.5
27
22
A03
ICPC
Fever
2.4
15.4
142
659
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.5
15.4
40
65
K65.0
ICD-10 Finland
Acute peritonitis
11.6
15.4
28
25
N05CF01
ATC
zopiclone; oral
2.0
15.4
236
1390
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
15.3
292
1869
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
29.3
15.3
20
7
WX882
NOMESCO Finland
High dependency care
5.1
15.2
48
99
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
15.2
98
370
EBA10
NOMESCO Finland
Surgical removal of tooth
2.7
15.2
112
461
JJ5AT
NOMESCO Finland
NA
46.0
15.1
18
*
ZX112
NOMESCO Finland
Subcutaneous
6.9
15.0
37
56
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
15.5
15.0
24
16
A10AA01
ATC
NA
5.7
14.9
43
80
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
11.6
14.9
27
24
A46
ICD-10 Finland
Erysipelas
2.6
14.9
114
480
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
57.9
14.8
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
14.8
262
1625
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.9
14.8
22
12
5AD01
NOMESCO Finland
NA
+∞
14.6
14
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
153.0
14.5
15
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
153.0
14.5
15
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
14.5
92
345
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
36.9
14.5
18
5
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
14.5
132
609
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.0
14.5
59
158
A07EC02
ATC
mesalazine; oral, rectal
3.7
14.4
64
185
B01AA03
ATC
warfarin; systemic
2.4
14.3
131
606
5BA08
NOMESCO Finland
NA
19.6
14.3
21
11
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
14.3
75
247
3AC01
NOMESCO Finland
NA
12.3
14.2
25
21
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.4
14.1
42
81
TPX15
NOMESCO Finland
Removal of vascular injection port
14.8
14.1
23
16
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.5
14.0
41
78
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
13.9
140
677
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
13.9
301
1996
WX402
NOMESCO Finland
General anaesthesia
2.3
13.9
150
751
K65.9
ICD-10 Finland
Peritonitis, unspecified
54.4
13.9
16
*
ZX197
NOMESCO Finland
NA
54.4
13.9
16
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.7
13.6
61
177
C08CA13
ATC
lercanidipine; oral
2.6
13.6
103
428
B59
ICD-10 Finland
Pneumocystosis
76.6
13.6
15
*
187
Kela drug reimbursment
MPA
+∞
13.6
13
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
34.8
13.5
17
5
XPX08
NOMESCO Finland
Intraoperative flow measurement
16.6
13.5
21
13
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.8
13.5
45
99
H05BX02
ATC
paricalcitol; systemic
142.6
13.5
14
*
WX610
NOMESCO Finland
Patient controlled analgesia
21.6
13.4
19
9
A10AA02
ATC
NA
4.8
13.3
44
96
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.9
13.3
86
327
B07.9
ICD-10 Finland
Verruca simplex
4.7
13.3
45
101
A28
ICPC
Limited function/disability NOS
2.6
13.3
99
410
S97
ICPC
Chronic ulcer skin
4.0
13.2
53
140
L04AA05
ATC
[U] tacrolimus; systemic
40.9
13.2
16
*
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
15.4
13.2
21
14
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
13.1
65
205
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
29.0
13.0
17
6
R11
ICD-10 Finland
Nausea and vomiting
3.1
13.0
75
264
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.9
13.0
29
38
WW409
NOMESCO Finland
Other aferesis
23.0
12.9
18
8
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.6
12.9
45
104
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
9.9
12.8
25
26
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
12.8
83
316
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
8.1
12.7
28
36
ED1AA
NOMESCO Finland
Mandipular X-ray examination
12.6
12.7
22
18
Z99.2
ICD-10 Finland
Dependence on renal dialysis
71.1
12.6
14
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
32.7
12.6
16
5
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.8
12.5
35
63
XG410
NOMESCO Finland
Flow-volume spirometry
4.3
12.5
46
112
K83.0
ICD-10 Finland
Cholangitis
7.8
12.5
28
37
J96.0
ICD-10 Finland
Acute respiratory failure
13.5
12.5
21
16
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
12.4
166
911
A06AD11
ATC
lactulose; oral
2.5
12.4
104
456
WZC30
NOMESCO Finland
Teaching
2.3
12.4
119
562
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
8.7
12.4
26
31
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
38.2
12.2
15
*
KBV10
NOMESCO Finland
Removal of stent from ureter
12.7
12.2
21
17
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
12.2
149
787
A07EA06
ATC
budesonide; oral, local oral
4.5
12.2
43
101
RJ410
NOMESCO Finland
NA
21.7
12.0
17
8
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
21.7
12.0
17
8
J02AC01
ATC
fluconazole; systemic
1.8
12.0
276
1841
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.8
12.0
50
137
L03AA13
ATC
pegfilgrastim; parenteral
4.0
12.0
48
127
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
11.9
77
291
RD210
NOMESCO Finland
NA
5.6
11.9
34
63
GDG10
NOMESCO Finland
Bilateral transplantation of lung
47.5
11.9
14
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
47.5
11.9
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
11.9
62
204
H02AB02
ATC
dexamethasone; systemic
2.6
11.8
89
367
H02AB07
ATC
prednisone; oral
2.4
11.7
110
510
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
66.0
11.6
13
*
L04AX04
ATC
lenalidomide; oral
19.3
11.6
17
9
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
19.3
11.6
17
9
R06.0
ICD-10 Finland
Dyspnoea
2.0
11.6
170
962
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.3
11.6
43
106
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.7
11.5
26
35
B01AB04
ATC
dalteparin; parenteral
3.8
11.5
49
137
WX110
NOMESCO Finland
Local anesthesy
1.8
11.4
491
3967
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
12.1
11.4
20
17
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.1
11.4
44
113
E83.50
ICD-10 Finland
Hypercalcemia
9.8
11.3
22
23
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
11.3
156
864
153
Kela drug reimbursment
Lenalidomid
17.4
11.2
17
10
J01CA04
ATC
amoxicillin; systemic
1.9
11.2
570
4847
1CX01
NOMESCO Finland
NA
25.5
11.2
15
6
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
11.1
76
298
A10AE05
ATC
insulin detemir; parenteral
3.2
11.1
58
191
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
11.4
11.1
20
18
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
9.4
11.1
22
24
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
44.0
10.9
13
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.5
10.9
85
360
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
10.9
101
469
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
15.8
10.9
17
11
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.5
10.9
51
155
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
10.8
56
184
C08CA05
ATC
nifedipine; systemic
3.2
10.7
56
185
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
60.9
10.6
12
*
7151
FHL
Kidney transplantation
60.9
10.6
12
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
60.9
10.6
12
*
TAB00
NOMESCO Finland
Lumbar puncture
3.5
10.6
50
152
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
10.6
313
2233
J01DB01
ATC
cefalexin; oral
1.9
10.6
577
4954
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.8
10.6
44
121
C02EA02
ATC
NA
4.1
10.6
40
101
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
7.5
10.5
24
33
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.5
10.5
83
354
C82.1
ICD-10 Finland
Follicular lymphoma grade II
14.5
10.5
17
12
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
10.5
51
159
HA1AA
NOMESCO Finland
X-ray mammography
2.9
10.5
62
223
WX204
NOMESCO Finland
Axillary plexus blockaced
4.5
10.4
36
83
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
10.4
10
*
J02AC04
ATC
posaconazole; systemic
+∞
10.4
10
*
0785X
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[VIROSIS ALIA CYTOMEGALICA]
+∞
10.4
10
*
ZXA10
NOMESCO Finland
Bilateral
2.1
10.4
135
727
GD2SN
NOMESCO Finland
Lung ventilation SPECT
16.3
10.4
16
10
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
10.4
51
161
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
33.0
10.4
13
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.0
10.3
21
24
GD1UN
NOMESCO Finland
Lung circulation SPECT
19.1
10.3
15
8
RJ420
NOMESCO Finland
NA
19.1
10.3
15
8
NHQ40
NOMESCO Finland
Amputation of toe
6.8
10.3
25
38
L01AA01
ATC
cyclophosphamide; systemic
23.8
10.3
14
6
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
10.1
91
416
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
10.1
129
691
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.4
10.0
23
32
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
14.8
10.0
16
11
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.2
10.0
53
177
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
40.7
10.0
12
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
40.7
10.0
12
*
I15.0
ICD-10 Finland
Renovascular hypertension
40.7
10.0
12
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.5
10.0
77
325
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
9.9
78
330
Z51.5
ICD-10 Finland
Palliative care
3.2
9.9
51
167
XF612
NOMESCO Finland
Measurement of central venous pressure
26.4
9.8
13
5
ZX100
NOMESCO Finland
Oral
8.9
9.8
20
23
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.7
9.8
24
37
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.2
9.8
36
89
K51.8
ICD-10 Finland
Other ulcerative colitis
7.5
9.8
22
30
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
5.7
9.7
27
49
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
9.7
64
245
N30.0
ICD-10 Finland
Acute cystitis
2.2
9.7
100
487
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
13.6
9.7
16
12
A40.8
ICD-10 Finland
Other streptococcal sepsis
13.6
9.7
16
12
120
Kela drug reimbursment
Hypogammaglobulinaemia
55.8
9.7
11
*
WX704
NOMESCO Finland
Intubation
2.6
9.6
68
273
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
8.5
9.6
20
24
K50.1
ICD-10 Finland
Crohn disease of large intestine
8.5
9.6
20
24
RJ411
NOMESCO Finland
NA
11.6
9.6
17
15
TQW99
NOMESCO Finland
Other minor procedure on skin
3.5
9.6
44
132
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
9.6
35
86
A12BA01
ATC
potassium chloride; oral
4.6
9.6
32
72
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
15.3
9.5
15
10
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.3
9.5
15
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
9.5
153
894
JN4CD
NOMESCO Finland
Very extensive body CT
3.7
9.5
41
117
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.7
9.5
31
68
B73
ICPC
Leukaemia
101.3
9.4
10
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.6
9.4
41
118
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
9.4
9
*
N0830, E102
ICD-10 Finland
NA
+∞
9.4
9
*
L04AA10
ATC
sirolimus; oral
+∞
9.4
9
*
ZX121
NOMESCO Finland
Central venous catheter
12.6
9.4
16
13
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
22.0
9.4
13
6
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
22.0
9.4
13
6
WW402
NOMESCO Finland
Leucoferesis
22.0
9.4
13
6
C10AA03
ATC
pravastatin; oral
2.9
9.4
58
214
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
9.3
65
256
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
9.3
65
257
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.8
9.3
25
44
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
7.4
9.3
21
29
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.9
9.2
29
61
H25.1
ICD-10 Finland
Senile nuclear cataract
2.0
9.2
130
723
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.5
9.1
26
49
B27.0
ICD-10 Finland
Gammaherpesviral mononucleosis
11.7
9.1
16
14
GD1LA
NOMESCO Finland
GD
7.2
9.1
21
30
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.2
9.1
47
155
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
37.2
9.0
11
*
RJ120
NOMESCO Finland
NA
37.2
9.0
11
*
WX720
NOMESCO Finland
Own respiration
3.4
9.0
43
133
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.1
9.0
49
167
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.6
9.0
22
34
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.4
9.0
42
128
H26.2
ICD-10 Finland
Complicated cataract
7.6
9.0
20
27
M05BX04
ATC
denosumab; parenteral
3.8
9.0
37
102
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
24.3
8.9
12
5
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
24.3
8.9
12
5
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
12.7
8.9
15
12
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.9
8.9
55
202
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
10.9
8.8
16
15
E0000UV
ATC
NA
1.7
8.8
262
1849
CKC12
NOMESCO Finland
Photocoagulation of retina
3.3
8.7
42
131
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
8.7
58
223
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
14.2
8.7
14
10
P01AB01
ATC
metronidazole; oral, rectal
1.7
8.7
259
1824
M10.3
ICD-10 Finland
Gout due to impairment of renal function
50.6
8.7
10
*
K65.8
ICD-10 Finland
Other peritonitis
50.6
8.7
10
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
7.8
8.7
19
25
A10AE04
ATC
insulin glargine; parenteral
2.4
8.7
76
341
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.3
8.7
22
36
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.6
129
731
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.4
8.6
18
22
E87.5
ICD-10 Finland
Hyperkalaemia
6.5
8.5
21
33
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
27.9
8.5
11
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
27.9
8.5
11
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
20.3
8.5
12
6
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
8.5
43
140
V03AG01
ATC
sodium cellulose phosphate; systemic
91.1
8.4
9
*
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
91.1
8.4
9
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
91.1
8.4
9
*
R31
ICD-10 Finland
Unspecified haematuria
2.4
8.4
73
328
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
12.9
8.4
14
11
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
12.9
8.4
14
11
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
+∞
8.3
8
*
N03AX16
ATC
pregabalin; oral
1.8
8.3
164
1020
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.9
8.3
26
55
R04.0
ICD-10 Finland
Epistaxis
2.7
8.3
56
218
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.4
8.3
72
324
L28
ICPC
Limited function/disability (L)
2.1
8.2
98
506
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.9
8.2
49
178
D64.8
ICD-10 Finland
Other specified anaemias
6.6
8.2
20
31
I50.0
ICD-10 Finland
Congestive heart failure
3.1
8.2
44
149
RS221
NOMESCO Finland
NA
6.1
8.2
21
35
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
8.2
52
196
E000001
ATC
NA
1.8
8.2
142
846
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
8.1
51
190
A04AA02
ATC
granisetron; systemic, transdermal
2.7
8.1
53
204
H3603, E113
ICD-10 Finland
NA
11.9
8.1
14
12
L01AA02
ATC
chlorambucil; oral
33.7
8.1
10
*
ZX196
NOMESCO Finland
NA
33.7
8.1
10
*
2AX04
NOMESCO Finland
NA
33.7
8.1
10
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
33.7
8.1
10
*
58209
ICD-8 Finland
Chronic nephritis, Unspecified
33.7
8.1
10
*
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
17.4
8.1
12
7
WX199
NOMESCO Finland
Other local analgesia
4.4
8.1
28
66
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.4
8.1
20
32
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
8.1
58
235
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
5.6
8.0
22
40
XX4BW
NOMESCO Finland
NA
22.3
8.0
11
5
N05BA06
ATC
lorazepam; systemic, sublingual
3.2
8.0
41
135
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.3
8.0
28
67
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.0
8.0
24
49
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.2
7.9
23
45
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.5
7.9
35
103
C03AA03
ATC
hydrochlorothiazide; oral
2.5
7.9
61
258
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
13.2
7.9
13
10
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
6.2
7.9
20
33
UKC02
NOMESCO Finland
Cystoscopy
2.0
7.9
107
584
A01AB09
ATC
miconazole; local oral
2.5
7.8
61
260
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
9.5
7.8
15
16
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
7.8
63
273
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.4
7.7
22
42
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
7.7
119
681
KAC00
NOMESCO Finland
Nephrectomy
15.2
7.7
12
8
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
15.2
7.7
12
8
WX725
NOMESCO Finland
Noninvasive ventilation
3.0
7.7
44
154
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
45.5
7.7
9
*
JN6AD
NOMESCO Finland
CT of torso and neck
6.0
7.7
20
34
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.7
7.7
52
202
C10AA04
ATC
fluvastatin; oral
2.5
7.7
60
256
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.7
7.7
52
203
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.7
7.7
32
90
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
25.3
7.6
10
*
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
25.3
7.6
10
*
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
25.3
7.6
10
*
WX202
NOMESCO Finland
Supraclavicular plexus blockade
6.3
7.6
19
31
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.5
7.6
21
39
C03DA01
ATC
spironolactone; oral
2.3
7.6
70
325
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
9.0
7.6
15
17
J96.1
ICD-10 Finland
Chronic respiratory failure
5.8
7.6
20
35
T89
ICPC
Diabetes insulin dependent
3.2
7.5
38
124
R18
ICD-10 Finland
Ascites
5.1
7.5
22
44
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
6.6
7.4
18
28
A01AB04
ATC
amphotericin B; local oral
3.1
7.4
39
131
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
80.9
7.4
8
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
80.9
7.4
8
*
B72
ICPC
Hodgkin Lymphoma
80.9
7.4
8
*
2BD01
NOMESCO Finland
NA
80.9
7.4
8
*
H3603, E107
ICD-10 Finland
NA
80.9
7.4
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
13.5
7.4
12
9
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
13.5
7.4
12
9
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.5
7.3
15
18
M01AH05
ATC
etoricoxib; oral
0.6
7.3
248
3231
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.3
579
5138
07959
ICD-8 Finland
Other viral diseases, Virosis cytomegalica NUD
+∞
7.3
7
*
4039A
ICD-9 Finland
Hypertensive renal disease, Unspecified
+∞
7.3
7
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
7.3
7
*
L01BB02
ATC
mercaptopurine; oral
6.3
7.3
18
29
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
7.2
65
298
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
7.4
7.2
16
22
D07AB08
ATC
desonide; topical
2.2
7.2
76
373
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
7.2
203
1396
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
30.3
7.2
9
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
20.2
7.1
10
5
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
20.2
7.1
10
5
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
6.7
7.1
17
26
JAH00
NOMESCO Finland
Laparotomy
4.1
7.1
26
65
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.7
7.1
29
80
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.6
7.1
23
51
WX730
NOMESCO Finland
Conventional respirator
5.4
7.1
20
38
K50.8
ICD-10 Finland
Other Crohn disease
5.4
7.1
20
38
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
5.4
7.1
20
38
K06.18
ICD-10 Finland
Another gingival hyperplasia
12.2
7.1
12
10
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
12.2
7.1
12
10
RJ421
NOMESCO Finland
NA
12.2
7.1
12
10
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.9
7.1
14
16
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
10.2
7.1
13
13
L57.0
ICD-10 Finland
Actinic keratosis
2.3
7.0
61
275
UJF92
NOMESCO Finland
Capsular endoscopy
4.5
7.0
23
52
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
7.0
40
141
H36.00
ICD-10 Finland
Diabetic background retinopathy
5.2
7.0
20
39
C09CA01
ATC
losartan; oral
1.7
6.9
152
973
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.0
6.9
26
67
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.4
6.9
31
93
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
6.9
42
156
329
Kela drug reimbursment
Lenalidomide
13.9
6.9
11
8
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
13.9
6.9
11
8
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
13.9
6.9
11
8
H26.4
ICD-10 Finland
After-cataract
2.4
6.9
54
231
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
8.4
6.8
14
17
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
8.4
6.8
14
17
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
6.8
167
1102
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.6
6.8
29
84
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
40.4
6.8
8
*
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
40.4
6.8
8
*
XX3ZW
NOMESCO Finland
NA
40.4
6.8
8
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
40.4
6.8
8
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
40.4
6.8
8
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.8
6.8
21
45
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.4
6.7
31
95
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.0
6.7
20
41
N43.3
ICD-10 Finland
Hydrocele, unspecified
5.0
6.7
20
41
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
6.7
100
564
3A422
NOMESCO Finland
NA
22.7
6.7
9
*
K05.31
ICD-10 Finland
Periodontitis pronounced
2.1
6.6
72
357
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.0
6.6
17
29
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.7
6.6
21
46
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.8
6.6
26
70
G04CA02
ATC
tamsulosin; oral
1.7
6.6
137
860
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
6.6
92
506
NGQ20
NOMESCO Finland
Amputation of lower leg
12.4
6.6
11
9
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
12.4
6.6
11
9
JMA10
NOMESCO Finland
Transabdominal total splenectomy
12.4
6.6
11
9
C02DE10
ATC
NA
8.8
6.6
13
15
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
6.6
346
2748
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
10.1
6.5
12
12
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
6.5
35
754
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.6
6.5
21
47
H36.01
ICD-10 Finland
Diabetic maculopathy
5.8
6.5
17
30
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.8
6.5
17
30
R05
ICD-10 Finland
Cough
1.8
6.5
125
770
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.6
6.5
27
77
S18
ICPC
Laceration/cut
1.5
6.4
274
2073
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
70.4
6.4
7
*
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
14.5
6.4
10
7
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
14.5
6.4
10
7
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
14.5
6.4
10
7
C09AA05
ATC
ramipril; oral
1.7
6.4
150
977
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.0
6.4
19
39
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.3
6.4
30
94
1XC02
NOMESCO Finland
NA
6.6
6.4
15
23
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
6.4
49
209
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
8.3
6.3
13
16
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.8
6.3
25
68
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
11.1
6.3
11
10
E21.2
ICD-10 Finland
Other hyperparathyroidism
11.1
6.3
11
10
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
18.2
6.3
9
5
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
18.2
6.3
9
5
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
18.2
6.3
9
5
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
18.2
6.3
9
5
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
6.3
6
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
6.3
6
*
B34.8
ICD-10 Finland
Other viral infections of unspecified site
+∞
6.3
6
*
J05AX18
ATC
letermovir; oral
+∞
6.3
6
*
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
+∞
6.3
6
*
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
6.3
6
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
6.3
6
*
E86
ICD-10 Finland
Volume depletion
4.2
6.2
22
54
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
26.9
6.2
8
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
26.9
6.2
8
*
N083, E102
ICD-10 Finland
NA
26.9
6.2
8
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
26.9
6.2
8
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.6
6.2
44
178
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.9
6.2
36
130
H3600, E103
ICD-10 Finland
NA
5.8
6.2
16
28
JAH01
NOMESCO Finland
Laparoscopy
2.9
6.2
35
123
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
7.8
6.1
13
17
E83.51
ICD-10 Finland
Hypocalcemia
12.7
6.1
10
8
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
12.7
6.1
10
8
XF402
NOMESCO Finland
ECG with work load test
2.0
6.1
77
410
R51.80
ICD-10 Finland
Headache
1.8
6.1
99
578
K72.9
ICD-10 Finland
Hepatic failure, unspecified
8.7
6.1
12
14
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.1
59
279
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.8
6.1
14
21
H47.1
ICD-10 Finland
Papilloedema, unspecified
10.1
6.0
11
11
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.5
6.0
46
194
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.7
6.0
24
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
258
158
23.96
322.10
1.6
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
254
154
24.03
318.42
1.6
1.4
u/ml
274.1
238.3
0.61
180
92
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
338
110
53.67
307.65
5.7
5.2
u/ml
753.9
2168.7
0.41
31
13
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
435
142
68.44
307.65
20.8
6.3
iu/ml
4491.3
271.1
1.03
259
17
(3026250) Tacrolimus [Mass/volume] in Blood
197
28
93.96
307.65
41.7
31.0
ug/l
7.4
6.9
0.71
179
23
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
265
134
29.51
307.65
2.2
1.6
u/ml
121.5
103.5
0.35
56
24
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
282
145
29.98
307.65
2.2
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
272
243
16.69
275.74
1.7
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
373
553
12.06
266.21
33.0
7.4
mmol/l
12.6
8.6
18.62
366
523
(3003458) Phosphate [Moles/volume] in Serum or Plasma
436
803
11.11
260.23
29.1
6.3
mmol/l
1.1
1.0
3.77
427
750
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
174
75
29.62
249.01
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
174
79
28.10
244.04
2.4
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
375
636
10.47
237.04
12.6
4.8
u/l
271.3
242.3
2.47
366
603
(40768446) Kidney Pathology biopsy report
116
26
52.28
199.62
2.4
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
194
165
15.34
199.28
4.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
191
166
14.94
193.43
4.2
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
272
392
10.14
192.85
3.6
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
297
510
8.81
180.59
6.5
2.6
g/l
8.7
10.3
6.38
283
472
(3042733) HLA Ab [Presence] in Serum
104
24
49.88
177.42
5.2
4.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
203
226
11.81
173.94
3.1
2.0
g/l
1.4
1.5
0.52
184
196
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
123
56
25.91
170.73
1.4
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
401
1003
7.20
168.31
14.5
4.1
mmol/l
0.8
0.8
4.18
389
947
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
357
802
7.39
166.98
7.5
2.4
%
24.1
23.5
0.29
311
693
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
264
436
8.66
164.87
12.5
4.2
ng/l
177.2
78.7
16.35
251
396
(3023368) Bacteria identified in Blood by Culture
512
1640
7.24
164.41
12.6
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
271
464
8.44
163.81
7.2
2.8
e9/l
72.7
72.3
0.04
205
350
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
87
13
75.25
160.84
6.0
6.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
362
857
7.04
159.55
7.4
2.3
g/l
2.1
2.4
16.61
352
801
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
378
946
6.84
156.83
4.5
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
340
770
7.08
156.42
3.0
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
309
639
7.37
155.63
7.8
3.0
%
2.0
1.8
3.35
298
589
(3022948) Iron [Moles/volume] in Serum or Plasma
372
927
6.79
154.73
7.4
2.3
umol/l
12.1
13.7
3.65
364
862
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
307
676
6.86
143.93
3.5
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
305
670
6.85
143.27
3.3
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
139
120
13.89
139.75
4.5
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
113
68
19.28
138.31
4.4
2.1
e9/l
1.5
1.1
1.41
69
40
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
137
118
13.88
137.88
2.6
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
265
526
7.13
137.29
10.7
4.3
%
0.8
0.8
0.20
160
163
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
152
155
11.95
137.10
2.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
251
474
7.35
136.44
10.0
4.3
%
0.6
0.4
2.13
124
117
(42870588) Differential panel, method unspecified - Blood
550
2119
6.48
136.37
22.0
6.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
162
184
10.86
135.35
4.8
6.2
u/ml
0.3
0.4
2.84
96
97
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
357
953
6.09
135.04
2.9
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
232
410
7.65
134.15
2.4
1.6
g/l
1.3
1.4
0.31
207
380
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
106
60
20.30
133.43
2.6
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
86
28
34.42
133.37
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
85
27
35.23
132.78
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
126
102
14.55
131.46
2.9
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
269
566
6.74
130.86
14.8
4.7
mmol/l
0.9
2.0
4.77
224
452
(3021447) Carbon dioxide [Partial pressure] in Venous blood
270
571
6.72
130.64
14.5
4.6
kpa
5.8
5.8
0.37
261
560
(44806118)
117
97
14.03
120.07
2.7
1.8
—
—
—
0
0
(44790049)
117
97
14.03
120.07
2.7
1.8
—
—
—
0
0
(44790048)
117
97
14.03
120.07
2.7
1.8
—
—
—
0
0
(44790047)
117
97
14.03
120.07
2.7
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
378
1157
5.42
119.64
3.0
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
239
496
6.52
116.75
2.1
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
106
78
15.58
116.47
3.2
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
74
23
35.46
116.09
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
451
1628
5.23
115.71
9.2
2.7
umol/l
374.9
6996.2
6.08
433
1414
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
149
186
9.68
115.22
3.9
2.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
72
21
37.69
114.99
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
324
907
5.42
113.12
3.4
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
153
204
9.10
112.14
4.5
3.9
g/l
3.1
3.7
2.87
147
198
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
89
52
19.20
109.98
3.2
2.1
%
10.8
12.2
0.24
41
31
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
70
22
34.87
109.36
4.6
2.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
88
51
19.33
109.14
4.7
2.2
e9/l
0.2
0.2
0.07
77
42
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
181
303
7.49
108.67
14.9
5.5
mmol/l
23.3
24.2
2.72
174
278
(3024561) Albumin [Mass/volume] in Serum or Plasma
573
2595
5.62
108.19
25.4
4.9
g/l
33.8
36.0
16.78
556
2430
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
88
53
18.60
107.12
4.6
2.1
e6/l
886.0
445.3
3.05
75
42
(3004809) Band form neutrophils/100 leukocytes in Blood
108
95
13.04
106.57
8.6
3.2
%
1.3
1.6
0.27
93
80
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
102
82
14.17
106.32
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
99
76
14.78
106.00
1.2
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
322
940
5.15
105.90
4.8
2.8
s
29.2
29.8
0.72
315
910
(3018418) pH of Serum or Plasma
462
1799
4.88
105.00
22.0
3.9
ph
7.4
7.4
0.52
106
335
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
104
89
13.34
104.35
2.7
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
103
88
13.34
103.43
2.4
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
89
60
16.63
102.26
3.8
1.9
%
29.2
35.7
—
14
6
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
62
16
42.03
102.07
1.7
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
84
51
18.35
101.76
3.1
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
602
2926
5.72
101.50
23.5
6.2
%
0.6
0.7
2.77
596
2739
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
157
243
7.85
100.89
3.5
2.1
ug/l
1.3
2.6
0.58
146
223
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
107
101
12.13
100.77
2.5
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
100
85
13.36
100.67
8.6
7.6
mg/l
11.6
10.4
1.19
90
77
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
88
60
16.41
100.48
4.5
1.9
e6/l
489.7
700.4
1.04
37
18
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
84
53
17.65
99.81
3.4
2.6
%
30.6
40.9
1.30
35
16
(3000991) Gas panel - Venous blood
227
519
5.77
98.60
19.2
11.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
371
1276
4.65
97.77
8.8
2.5
e6/l
3.5
5.6
2.14
352
1121
(3019069) Monocytes/100 leukocytes in Blood
607
3038
5.58
96.65
25.6
6.5
%
8.6
8.7
0.16
601
2855
(3001604) Monocytes [#/volume] in Blood
626
3215
5.90
96.38
20.8
6.1
e9/l
0.6
0.6
1.77
594
2776
(3006315) Basophils [#/volume] in Blood
627
3227
5.91
96.19
20.9
6.1
e9/l
0.0
0.0
5.24
595
2791
(3006504) Eosinophils/100 leukocytes in Blood
604
3023
5.50
95.83
24.2
6.2
%
2.2
2.9
14.53
595
2823
(4035726)
231
550
5.56
95.62
2.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
104
106
11.17
92.80
2.9
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
610
3124
5.45
92.63
24.5
6.2
%
28.8
28.5
0.18
603
2921
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
598
3022
5.27
92.21
43.8
7.4
mmol/l
1.2
1.2
0.35
542
2584
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
567
2758
4.92
91.78
32.2
7.0
mmol/l
1.2
1.2
0.49
553
2508
(3019198) Lymphocytes [#/volume] in Blood
628
3311
5.70
91.31
21.3
6.1
e9/l
2.2
2.0
0.31
603
2931
(3013115) Eosinophils [#/volume] in Blood
630
3333
5.73
91.11
23.1
6.5
e9/l
0.1
0.2
12.71
600
2938
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
501
2235
4.50
91.00
12.3
3.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
603
3087
5.28
90.85
22.6
6.0
%
56.7
56.5
0.08
597
2901
(3026782) Osmolality of Urine
346
1186
4.46
90.30
9.8
2.6
mosm/kgh2o
483.2
561.6
11.83
326
1010
(3021440) Promyelocytes/100 leukocytes in Blood
214
499
5.54
90.29
11.6
4.4
%
0.1
0.1
0.72
150
147
(3002582) Erythrocytes [#/volume] in Urine
444
1877
4.19
85.44
11.7
3.1
e6/l
31.0
91.6
1.00
411
1432
(3025159) Blasts/100 leukocytes in Blood
202
469
5.47
85.29
10.8
4.5
%
0.0
0.1
0.33
127
123
(3033658) Prothrombin time (PT) actual/Normal
395
1551
4.15
84.19
13.1
4.2
%
95.1
92.1
1.53
390
1521
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
110
140
8.99
82.91
2.2
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
52
15
37.08
82.89
1.5
3.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
611
3286
5.04
82.84
25.3
6.6
umol/l
11.6
11.8
0.11
606
3121
(3030467) Casts [#/volume] in Urine by Automated count
417
1716
4.09
82.75
10.8
3.0
e6/l
0.3
0.4
0.34
373
1275
(3020630) Protein [Mass/volume] in Serum or Plasma
197
465
5.34
81.34
6.2
2.8
g/l
62.2
67.0
11.13
185
426
(3037692) Legionella sp identified in Specimen by Organism specific culture
60
29
22.34
80.23
2.1
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
132
218
7.09
79.16
3.3
4.7
%
87.2
89.7
0.40
126
207
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
86
84
11.39
78.75
4.6
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
81
73
12.27
78.21
4.7
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
404
1684
3.92
77.43
9.9
3.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
641
3708
5.19
75.38
35.1
9.6
e9/l
4.0
4.0
0.16
616
3235
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
241
721
4.40
73.46
13.3
3.1
umol/l
8.8
8.2
0.20
221
635
(3032080) INR in Blood by Coagulation assay
497
2441
3.88
73.13
19.9
8.0
inr
1.1
1.2
1.55
160
711
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
219
619
4.54
71.77
5.1
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
463
2191
3.76
71.67
13.3
3.6
e6/l
113.7
86.1
0.25
418
1542
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
287
999
3.97
70.54
7.4
2.9
e6/l
2.1
2.1
0.01
200
541
(3004119) Hemoglobin [Mass/volume] in Venous blood
165
376
5.30
70.31
11.8
3.8
g/l
109.3
129.3
22.12
156
371
(3007853) Bacteria identified in Skin by Aerobe culture
241
746
4.24
69.78
2.4
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
182
458
4.88
68.84
10.8
5.2
kpa
4.9
5.2
3.34
171
431
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
122
215
6.55
68.36
2.0
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
180
453
4.87
68.02
10.8
5.3
ph
7.4
7.4
0.55
33
56
(3037756) Immunofixation for Serum or Plasma
89
113
8.77
66.87
3.2
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
161
375
5.16
66.68
5.5
2.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
86
105
9.09
66.67
12.4
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
290
1060
3.77
65.64
6.4
2.7
e6/l
0.7
1.1
1.57
200
596
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
173
434
4.84
65.47
11.0
5.4
mmol/l
0.9
1.6
1.70
131
335
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
423
1975
3.51
65.06
8.1
2.5
u/l
55.2
57.3
0.53
406
1831
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
347
1446
3.53
63.79
3.5
2.1
mg/l
3.1
3.1
0.13
323
1230
(3045142) Bone marrow Pathology biopsy report
74
79
10.25
63.42
1.9
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
506
2688
3.54
62.16
7.4
2.7
ug/l
337.8
127.4
10.54
498
2490
(3014111) Lactate [Moles/volume] in Serum or Plasma
192
543
4.37
62.13
15.4
9.5
mmol/l
1.3
1.3
0.04
186
523
(3000494) Fungus identified in Specimen by Culture
240
808
3.85
60.77
3.3
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
39
12
34.17
60.75
4.8
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
484
2533
3.42
60.28
4.9
2.3
nmol/l
75.0
75.6
0.18
475
2276
(3016502) Oxygen saturation in Arterial blood
203
615
4.12
59.64
14.5
10.6
%
94.8
95.9
1.40
193
592
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
101
170
6.68
58.94
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
67
69
10.53
58.85
1.9
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
150
365
4.85
58.56
2.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
89
132
7.49
58.43
2.7
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
87
126
7.65
58.33
9.5
2.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
131
287
5.29
57.86
10.6
3.4
mmol/l
24.1
25.2
2.47
122
280
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
82
112
8.07
57.83
1.1
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
144
343
4.93
57.64
1.8
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
407
1963
3.26
57.32
7.8
2.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
43
21
21.62
56.96
2.9
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
211
678
3.90
56.79
14.5
10.1
kpa
11.5
12.4
1.83
197
653
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
211
678
3.90
56.79
14.5
10.1
kpa
4.8
5.2
4.86
199
652
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
345
1518
3.29
56.64
6.0
2.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
99
172
6.45
55.93
7.1
3.8
mg/l
72.3
88.8
0.17
80
142
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
99
172
6.45
55.93
7.1
3.8
mg/l
38.6
32.1
0.69
80
142
(3015235) Bicarbonate [Moles/volume] in Capillary blood
97
166
6.54
55.62
5.9
3.9
mmol/l
22.9
25.2
5.17
87
145
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
98
170
6.45
55.44
7.1
3.8
ratio
1.6
2.0
—
6
20
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
105
195
6.07
55.44
3.8
3.1
%
209.4
186.4
1.47
99
187
(3013826) Glucose [Moles/volume] in Serum or Plasma
596
3653
3.72
55.20
21.7
5.2
mmol/l
6.8
6.7
0.82
577
3430
(3003396) Base excess in Arterial blood by calculation
208
676
3.84
54.89
14.5
10.1
mmol/l
0.0
1.2
3.89
163
536
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
192
598
3.94
53.79
5.1
2.4
g/l
0.2
0.2
0.04
179
559
(40758558) Short blood count panel - Blood
349
1593
3.16
53.08
24.0
7.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
173
505
4.12
53.03
6.6
2.4
ml/min/173m2
40.9
71.3
17.35
89
200
(3000093) Morphology [Interpretation] in Blood Narrative
57
54
11.31
52.94
1.4
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
360
1676
3.14
52.84
5.9
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
83
128
7.14
52.48
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
84
132
7.01
52.19
6.7
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
82
129
6.99
50.86
11.4
4.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
50
43
12.36
49.39
3.4
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
181
573
3.82
49.18
15.9
10.6
g/l
108.3
122.0
14.47
171
553
(3036489) Thrombin time
112
247
5.13
48.79
3.4
3.1
s
22.5
21.8
0.42
105
227
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
33
12
28.68
48.64
2.8
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
46
36
13.52
48.10
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
46
36
13.52
48.10
1.1
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
407
2111
2.95
47.95
12.2
3.4
u/l
39.5
33.4
1.10
396
2013
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
37
19
20.40
47.86
6.5
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
56
60
9.98
47.67
5.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
56
60
9.98
47.67
5.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
56
60
9.98
47.67
5.7
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
38
21
18.98
47.58
7.2
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
38
21
18.98
47.58
7.2
2.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
41
27
15.98
47.14
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
54
56
10.29
47.05
9.9
3.0
%
54.6
53.7
0.07
37
41
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
38
22
18.11
46.55
7.2
2.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
183
604
3.66
46.54
3.1
2.2
nmol/l
341.7
370.2
0.77
172
566
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
56
62
9.66
46.52
1.1
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
320
1477
2.99
46.41
13.3
4.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
49
45
11.56
46.38
3.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
41
28
15.40
46.23
2.9
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
53
56
10.08
45.55
1.5
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
40
27
15.57
45.37
7.1
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
40
27
15.57
45.37
7.1
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
40
27
15.57
45.37
7.1
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
40
27
15.57
45.37
7.1
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
494
2899
2.94
45.26
33.2
9.3
e9/l
0.0
0.0
0.60
423
2359
(3007164) IgA [Mass/volume] in Serum or Plasma
293
1307
3.00
44.95
2.3
1.4
g/l
2.1
2.4
2.25
233
811
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
40
28
15.01
44.49
2.9
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
46
41
11.86
44.36
1.1
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
74
121
6.65
44.14
5.6
2.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
126
331
4.35
44.06
20.7
14.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
496
2944
2.90
43.99
11.5
3.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
42
11.58
43.67
1.8
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
57
71
8.59
43.19
10.8
3.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
121
6.56
42.96
9.0
4.0
%
53.2
56.7
0.87
73
121
(3000060) B lymphocytes [#/volume] in Blood
38
26
15.32
42.76
3.2
2.0
e6/l
292.5
366.7
0.21
16
12
(3001964) Herpes simplex virus Ag [Presence] in Specimen
33
17
20.23
42.55
3.0
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
681
4886
4.22
42.52
36.0
7.5
u/l
89.8
79.5
2.94
674
4596
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
80
148
5.91
42.14
3.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
134
382
4.03
41.87
10.1
6.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
605
4059
3.23
41.70
10.6
4.0
e6/l
21.6
1812.6
—
8
64
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
39
30
13.64
41.10
3.0
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
82
159
5.65
41.07
6.6
3.2
umol/l
34.4
35.1
0.08
75
129
(3011648) Oxygen content in Venous blood
49
54
9.62
40.78
10.7
6.0
%
10.9
10.7
0.15
49
54
(3021960) Folate [Moles/volume] in Serum or Plasma
293
1371
2.83
40.35
1.9
1.5
nmol/l
18.2
20.8
2.33
270
1167
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
31
13.19
40.31
3.1
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
72
126
6.20
40.11
5.1
2.5
%
15.3
16.7
1.83
52
68
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
20
17.19
39.45
2.5
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
74
136
5.91
39.20
4.1
2.3
g/l
120.2
132.2
3.34
59
103
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
72
131
5.96
38.53
1.5
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
34
12.02
38.07
3.0
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
42
41
10.77
38.07
7.6
3.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
344
1788
2.66
38.02
8.9
3.2
mg/l
1151.3
238.3
1.87
292
1148
(3037467) Urinalysis macro (dipstick) panel - Urine
617
4303
3.12
37.31
14.4
3.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
69
125
5.96
37.06
10.9
3.6
mmol/l
2.8
2.5
0.20
47
84
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
99
246
4.47
36.98
11.7
7.1
%
1.6
1.6
0.25
87
232
(3022313) Gas panel - Capillary blood
119
341
3.94
36.71
12.8
5.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
33
23
14.94
36.69
3.3
2.0
ug/l
65.5
70.0
0.07
33
23
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
44
49
9.46
36.29
1.8
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
364
1981
2.58
36.11
8.6
3.1
mmol/l
6.0
8.0
20.51
344
1652
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
344
1830
2.58
35.70
4.0
2.1
u/l
129.1
278.9
2.08
330
1732
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
88
207
4.67
35.17
4.0
2.2
ug/l
293.3
487.9
0.43
81
194
(3015377) Calcium [Moles/volume] in Serum or Plasma
365
2014
2.53
34.84
11.0
3.5
mmol/l
2.3
2.4
4.87
350
1776
(3010421) pH of Blood
74
152
5.28
34.68
12.8
3.4
ph
7.4
7.4
0.53
67
123
(3023419) Bacteria identified in Sputum by Culture
55
85
6.89
34.49
3.0
2.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
104
285
4.06
34.05
2.8
1.4
u/ml
14.0
8.3
—
6
8
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
45
56
8.47
34.03
5.4
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
284
1408
2.60
33.76
3.6
2.0
mg/l
2.3
1.2
1.16
247
1074
(40757373) Influenza virus identified in Isolate
27
15
18.61
33.53
2.4
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
63
115
5.87
33.53
1.8
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
44
55
8.42
33.15
7.8
3.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
94
244
4.25
33.08
12.3
7.2
%
0.9
0.9
0.40
81
230
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
48
67
7.57
32.97
3.9
2.0
pg
33.4
32.8
0.34
48
67
(3007566) Smooth muscle Ab [Titer] in Serum
79
180
4.77
32.78
1.4
1.2
titre
94.4
66.7
—
9
12
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
157
580
3.14
32.44
5.9
2.4
u/l
36.0
116.2
0.48
146
494
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
241
1121
2.67
32.43
6.8
3.7
ng/l
658.0
427.1
0.43
206
842
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
24
11
22.48
32.30
3.2
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
42
52
8.48
31.87
1.3
1.2
titre
215.0
80.0
—
10
8
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
32
27
12.32
31.81
3.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
32
27
12.32
31.81
3.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
342
1893
2.44
31.64
10.2
4.0
mg/mmol
26.6
8.5
3.78
292
1189
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
106
310
3.80
31.59
14.8
13.5
mmol/l
23.3
24.4
3.48
99
292
(3019832) Treponema pallidum Ab [Presence] in Serum
153
565
3.13
31.57
2.2
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
222
1004
2.70
31.48
2.1
1.7
nmol/l
1226.7
1211.8
0.08
187
763
(3047181) Lactate [Moles/volume] in Blood
78
182
4.65
31.41
15.9
9.2
mmol/l
1.2
1.3
0.22
64
157
(3008152) Bicarbonate [Moles/volume] in Arterial blood
118
373
3.55
31.32
13.8
8.9
mmol/l
23.4
24.6
2.25
108
348
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
213
4.36
31.28
7.5
2.3
g/l
7.0
7.4
1.05
66
166
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
213
4.36
31.28
7.5
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
213
4.36
31.28
7.5
2.3
g/l
3.2
3.8
3.27
63
158
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
82
200
4.47
31.24
7.2
2.4
g/l
3.1
3.2
0.04
64
160
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
310
1655
2.45
30.92
5.5
3.2
ng/l
3387.2
998.6
5.45
294
1402
(3030981) Hyaline casts [#/volume] in Urine by Automated count
109
334
3.63
30.29
8.7
2.6
e6/l
0.3
0.2
0.24
109
321
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
110
342
3.58
29.89
2.5
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
201
886
2.71
29.80
1.7
1.3
titre
545.0
492.1
0.13
48
185
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
76
185
4.45
28.99
5.9
2.6
g/l
0.5
1.0
0.77
68
168
(3018572) Chloride [Moles/volume] in Blood
63
132
5.11
28.80
16.5
10.8
mmol/l
104.4
105.8
1.02
52
119
(3039000) Anion gap in Blood
63
132
5.11
28.80
16.4
10.7
mmol/l
12.0
11.3
0.82
52
119
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
195
4.34
28.75
7.4
2.4
g/l
8.3
10.7
4.73
68
171
(21494890) Protein electrophoresis panel - 24 hour Urine
40
54
7.76
28.23
3.5
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
75
185
4.38
28.11
6.6
3.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
37
46
8.40
27.95
3.9
1.4
g/l
1.0
1.0
0.27
37
46
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
201
4.20
27.61
1.8
1.5
iu/ml
0.0
0.0
1.21
14
37
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
28
24
12.07
27.51
1.1
1.0
miu/ml
1581.4
1728.1
0.21
28
24
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
388
2375
2.27
27.27
2.3
1.9
pmol/l
99.6
94.6
1.49
242
1246
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
33
37
9.27
26.99
1.6
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
33
37
9.27
26.99
1.6
2.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
33
8
43.05
26.97
11.5
3.9
mmol/l
5.1
7.0
—
33
8
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
38
51
7.78
26.94
1.4
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
317
1794
2.30
26.81
1.8
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
37
50
7.72
26.07
3.8
2.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
51
97
5.56
25.92
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
51
97
5.56
25.92
1.9
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
47
83
5.96
25.82
4.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
467
3140
2.22
25.36
10.1
3.4
estimate
0.0
0.0
0.80
130
560
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
58
7.03
25.26
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
85
5.82
25.19
4.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
47
85
5.82
25.19
4.4
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
460
3099
2.19
24.52
10.2
3.3
estimate
0.0
0.0
0.00
129
576
(3021601) Nitrite [Presence] in Urine by Test strip
461
3111
2.19
24.43
13.5
4.6
estimate
0.0
0.0
0.00
134
588
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
30
35
8.88
23.78
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
617
4723
2.50
23.68
10.2
4.0
mm/h
20.8
11.0
25.73
602
4365
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
119
445
2.98
23.65
6.9
3.4
ng/l
265.6
164.1
1.50
111
400
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
23
11.20
23.43
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
45
84
5.63
23.32
4.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
45
84
5.63
23.32
4.5
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
23
19
12.44
23.05
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
45
85
5.56
23.03
4.5
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
77
224
3.71
22.95
2.2
1.6
g/l
0.3
0.2
0.84
70
213
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
79
234
3.65
22.93
2.2
1.6
g/l
1.1
1.2
1.46
73
224
(3014765) Yersinia sp identified in Stool by Organism specific culture
68
183
3.98
22.63
1.5
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
68
183
3.98
22.63
1.5
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
28
32
9.04
22.53
2.7
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
18
10
18.40
22.15
1.9
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
68
186
3.91
22.12
1.5
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
91
304
3.26
21.88
14.8
6.0
mmol/l
24.1
24.8
1.40
91
294
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
53
121
4.63
21.83
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
169
789
2.46
21.56
4.2
2.3
ug/g
213.3
118.3
3.28
149
626
(3037121) Protein [Mass/volume] in Urine
76
229
3.57
21.48
8.6
3.8
g/l
0.4
0.3
0.20
56
107
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
74
221
3.60
21.19
7.0
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
37
64
6.02
20.73
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
363
2339
2.04
20.51
5.0
3.5
ng/l
72.2
37.5
0.88
296
1594
(3044290) Cell count panel - Cerebral spinal fluid
50
115
4.58
20.40
2.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
40
76
5.49
20.33
2.5
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
121
498
2.69
19.95
2.6
2.4
ug/l
16.5
7.1
1.36
110
447
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
21
19
11.33
19.84
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
27
36
7.73
19.19
4.9
2.3
min
487.3
496.3
0.16
27
22
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
63
182
3.68
18.93
1.2
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
35
63
5.77
18.82
1.4
1.5
g/l
27.0
33.6
1.77
30
54
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
9
28.64
18.82
2.7
5.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
53
136
4.11
18.79
1.6
1.2
mmol/l
3.8
3.8
0.15
47
127
(40768795) Lymph node Pathology biopsy report
35
64
5.68
18.52
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
248
1434
2.07
18.46
7.5
3.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
35
7.65
18.33
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
62
182
3.62
18.19
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
59
5.80
17.87
1.5
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
201
3.44
17.62
1.2
1.4
miu/ml
381.7
230.2
1.07
12
95
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
46
112
4.30
17.47
1.4
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
26
8.68
17.20
1.1
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
14
12.39
16.96
5.2
2.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
16
12
13.59
16.83
1.9
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
65
207
3.34
16.82
3.7
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
51
140
3.83
16.48
1.8
1.2
e6/l
3.3
10.2
0.76
42
113
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
51
140
3.83
16.48
1.9
1.3
e6/l
223.2
895.0
0.41
45
115
(3023199) Leukocytes [#/volume] in Pleural fluid
30
53
5.85
16.44
1.5
1.3
e6/l
725.0
3263.5
1.49
21
32
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
40
6.69
16.28
8.3
3.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
69
233
3.15
16.22
2.0
1.6
titre
560.0
180.0
—
5
11
(40761535) Cells panel - Urine sediment
114
504
2.48
16.08
9.4
3.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
13
12.55
16.07
1.8
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
98
4.36
15.94
1.4
1.2
u/ml
3.6
4.7
0.30
21
41
(3000570) Elastase.pancreatic [Mass/mass] in Stool
59
185
3.37
15.64
1.5
1.4
ug/g
278.5
296.7
0.28
42
110
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
19
9.67
15.27
3.4
1.5
e6/l
4204.6
5584.1
—
7
11
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
25
40
6.42
15.09
6.8
7.0
u/ml
30.5
79.2
—
8
13
(40768804) Tissue Pathology biopsy report
359
2481
1.83
14.96
3.0
2.0
—
—
—
0
0
(4306422)
39
95
4.27
14.80
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
95
4.27
14.80
1.4
1.2
u/ml
1.8
4.6
0.55
17
29
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
8
25.60
14.74
1.2
1.3
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
18
20
9.19
14.71
3.2
4.1
au/ml
117.2
34.2
—
7
5
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
98
4.14
14.22
1.3
1.6
g/l
0.6
0.8
0.65
23
75
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
21
8.75
14.18
12.9
9.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
33
6.83
14.09
4.5
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
24
8.09
14.07
1.1
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
14
10.91
13.79
1.7
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
29
59
5.07
13.67
1.3
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
17
5
34.70
13.54
3.6
4.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
67
247
2.87
13.50
1.3
1.2
u/ml
1.5
1.6
—
6
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
38
6.21
13.46
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
103
3.93
13.31
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
53
5.24
13.24
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
95
4.04
13.11
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
550
4418
1.84
13.10
9.9
3.1
u/l
70.9
50.0
4.23
528
4159
(3026389) Candida sp identified in Specimen by Organism specific culture
32
74
4.47
12.97
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
13
10.95
12.89
1.6
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
60
215
2.94
12.72
2.2
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
55
5.05
12.71
3.1
3.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
5
32.62
12.61
3.4
4.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
50
162
3.23
12.58
1.5
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
19
8.58
12.40
2.6
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
19
28
6.93
12.34
3.2
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
6
27.18
12.08
1.3
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
16
6
27.18
12.08
2.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
79
4.18
11.95
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
20
8.15
11.92
2.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
203
1250
1.85
11.76
1.8
1.7
pmol/l
513.2
4808117.4
0.50
182
1040
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
15
5
30.54
11.67
20.6
21.2
umol/l
0.3
0.2
—
15
5
(3029937) Albumin [Presence] in Urine by Test strip
253
1670
1.76
11.59
11.7
3.6
estimate
0.0
0.0
0.69
126
569
(3022217) INR in Platelet poor plasma by Coagulation assay
131
700
2.05
11.53
27.3
20.7
inr
1.3
1.2
0.31
18
99
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
330
2.48
11.53
1.6
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
18
8.48
11.52
1.6
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
57
211
2.84
11.40
1.7
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
41
5.49
11.40
1.5
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
16
22
7.40
11.02
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
62
246
2.65
10.87
10.0
5.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
88
411
2.29
10.87
1.7
1.3
u/ml
344.5
249.1
0.18
68
379
(3002385) Erythrocyte distribution width [Ratio]
636
5466
1.91
10.79
73.1
16.3
%
14.6
13.6
28.92
630
5354
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
14
5
28.46
10.75
1.1
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
139
777
1.96
10.74
1.4
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
20
7.63
10.59
12.6
9.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
44
5.12
10.57
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
37
111
3.45
10.53
4.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
18
7.90
10.17
1.3
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
14
18
7.90
10.17
3.7
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
62
4.30
10.16
1.4
1.2
g/l
2.1
2.6
0.62
13
42
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
62
4.30
10.16
1.4
1.2
g/l
0.4
0.3
0.57
13
42
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
62
4.30
10.16
1.4
1.2
g/l
6.9
6.9
0.01
13
43
(3041096) Erythrocytes [Presence] in Urine by Automated
253
1721
1.70
10.16
10.6
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
148
861
1.89
10.11
1.4
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
50
4.71
10.06
1.5
1.3
e6/l
4925.6
49090.0
2.43
13
25
(4062490)
26
63
4.24
9.96
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
17
28
6.19
9.96
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
12
13
9.36
9.89
3.3
1.8
—
—
—
0
0
(3025315) Body weight
13
5
26.39
9.83
3.7
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
715
6462
2.35
9.77
70.8
13.1
mg/l
20.5
23.4
2.70
685
5039
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
19
7.49
9.72
1.7
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
48
4.69
9.58
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
48
4.69
9.58
1.2
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
11
10.13
9.56
2.4
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
11
10.13
9.56
2.4
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
11
10.13
9.56
2.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
253
1744
1.67
9.56
2.2
1.7
mmol/l
1.5
1.4
1.54
243
1465
(4268621)
26
66
4.04
9.38
2.3
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
328
2424
1.61
9.33
10.8
3.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
20
7.11
9.31
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
17
7.76
9.30
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
17
7.76
9.30
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
17
7.76
9.30
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
26
67
3.98
9.20
1.1
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
165
2.83
9.18
5.4
2.4
ug/min
285.7
74.0
0.76
36
94
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
57
237
2.52
9.10
3.0
3.7
u/ml
137.5
5308.2
0.67
52
206
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
64
4.00
8.93
3.9
2.5
umol/l
29.9
10.4
0.80
19
44
(3000012) Reticulocyte production index
16
28
5.81
8.83
2.0
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
61
266
2.40
8.80
5.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
532
4451
1.62
8.69
6.6
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
44
4.64
8.63
1.8
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
75
3.69
8.62
1.3
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
8
16.50
8.57
2.9
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
239
2.45
8.47
2.5
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
512
4275
1.58
8.15
4.1
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
97
525
1.97
8.15
13.8
3.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
55
4.09
8.11
1.1
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
7
17.39
8.09
1.3
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
27
5.65
8.04
1.4
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
21
51
4.20
8.04
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
102
566
1.92
7.96
24.8
4.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
106
601
1.88
7.75
3.3
4.5
ug/l
27.0
32.1
0.09
93
501
(3018405) Lactate [Moles/volume] in Arterial blood
51
219
2.42
7.63
4.7
4.6
mmol/l
1.5
1.4
0.32
51
213
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
18
6.76
7.62
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
19
6.40
7.26
2.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
16
6.96
7.16
4.6
3.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
56
3.83
7.12
1.3
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
83
446
1.96
7.11
4.0
3.1
e9/l
4.5
4.0
0.63
69
355
(3035933) Granulocytes/100 leukocytes in Blood
14
27
5.26
6.99
1.8
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
20
6.08
6.92
1.2
1.5
—
—
—
0
0
(3013512) EKG study
244
1779
1.54
6.88
5.9
3.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
11
17
6.55
6.79
1.1
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
10
6
16.86
6.76
2.5
1.7
ng/l
258.9
107.7
—
10
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
25
5.27
6.50
1.6
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
18
6.18
6.44
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
159
1065
1.62
6.41
4.3
3.0
mmol/l
2.5
2.4
0.61
146
946
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
77
3.18
6.21
1.5
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
8
12.64
6.09
1.3
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
710
0.40
6.06
1.1
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
15
35
4.35
6.04
1.7
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
15
35
4.35
6.04
2.4
4.7
ph
7.4
7.4
—
6
11
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
6
15.15
5.91
1.1
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
116
731
1.69
5.91
2.0
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
93
553
1.77
5.82
2.9
2.1
nmol/l
14.0
13.2
0.41
87
496
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
30
114
2.70
5.79
1.1
1.1
iu/ml
29.7
77.6
—
9
28
(3047007) Chlamydophila sp Ab [Presence] in Serum
29
110
2.70
5.63
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
172
1209
1.54
5.58
1.6
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
52
259
2.08
5.52
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
192
2.26
5.51
1.7
1.5
u/l
10.2
8.7
0.34
37
157
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
25
4.86
5.51
4.2
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
57
3.39
5.47
1.2
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
5
16.15
5.42
1.8
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
174
2.31
5.41
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
185
2479
0.67
5.39
4.0
2.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
18
5.62
5.33
1.2
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
708
6612
1.81
5.23
75.6
15.1
mmol/l
138.8
139.7
17.04
701
6436
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
0
+∞
5.21
6.2
0.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
367
1.87
5.14
3.4
3.2
pmol/l
4.2
4.7
2.52
53
323
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
9
10.10
5.03
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
9
10.10
5.03
1.9
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
32
4.11
4.91
1.5
4.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
32
4.11
4.91
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
638
0.43
4.90
1.8
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
708
6632
1.77
4.89
78.6
15.1
mmol/l
4.1
4.0
10.82
700
6446
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
287
1.95
4.82
2.6
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
438
0.33
4.79
1.6
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
10
9.09
4.79
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
20
5.05
4.78
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
5
14.11
4.58
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
13
34
3.87
4.55
1.1
1.1
u/l
40.7
13.2
1.50
13
27
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
117
2.45
4.52
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
49
3.31
4.49
1.3
1.2
—
68.0
—
0
7
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
36
171
2.16
4.35
1.3
1.2
u/ml
1.8
2.7
—
7
20
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
171
2.16
4.35
1.3
1.2
u/ml
2.0
6.2
—
7
28
(3040151) Glucose [Moles/volume] in Capillary blood
20
72
2.82
4.31
3.6
9.4
mmol/l
6.6
7.1
0.29
20
58
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
22
4.59
4.31
3.1
4.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
6
11.76
4.28
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
23
90
2.60
4.25
3.4
2.9
nmol/l
1.1
0.9
0.44
11
73
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
13
36
3.66
4.22
1.1
1.1
u/l
93.3
92.4
0.01
13
30
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
10
23
4.39
4.10
1.3
1.0
%
83.6
86.3
—
5
13
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
10
23
4.39
4.10
1.2
1.7
%
98.8
88.1
—
5
13
(3021788) Differential panel - Synovial fluid
25
104
2.45
4.09
1.6
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
10
8.07
4.06
1.1
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
42
3.38
4.06
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
71
2.72
3.85
2.2
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
5
12.08
3.77
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
5
12.08
3.77
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
342
0.34
3.69
2.2
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
19
73
2.64
3.66
1.4
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
192
1.97
3.59
1.6
2.1
u/l
8130.8
2229.9
—
9
66
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
41
3.21
3.51
1.1
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
13
6.20
3.50
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
13
6.20
3.50
1.1
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
6
10.06
3.50
1.2
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
6
10.06
3.50
2.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
31
154
2.06
3.39
2.0
1.6
e6/l
8230.9
14214.4
0.77
26
121
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
18
5.05
3.37
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
7
10
7.05
3.37
4.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
535
4861
1.32
3.22
4.7
3.8
pmol/l
14.7
14.7
0.07
511
4416
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
33
3.37
3.20
1.1
1.1
iu/ml
216.6
253.3
0.12
11
33
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
15
5.38
3.19
1.6
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
61
384
1.64
3.16
6.3
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
178
1391
1.36
3.15
9.0
3.6
kg/l
1.0
1.0
0.18
25
188
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
67
2.57
3.14
2.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
16
5.04
3.05
1.4
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
141
2.02
2.98
1.5
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
76
2.40
2.91
1.8
1.5
%
51.1
58.2
0.26
12
55
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
13
5.42
2.87
1.9
1.4
—
—
—
0
0
(4027681)
12
41
2.96
2.87
1.4
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
18
4.48
2.80
2.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
97
2.20
2.79
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
124
2.05
2.79
1.6
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
125
2.03
2.73
1.6
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
296
1.66
2.72
12.1
2.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
11
37
3.00
2.70
1.0
1.4
—
25.8
—
0
6
(3041354) Potassium [Moles/volume] in Venous blood
18
79
2.31
2.69
3.0
2.5
mmol/l
4.3
4.0
1.40
18
79
(3035285) Chloride [Moles/volume] in Venous blood
18
79
2.31
2.69
3.0
2.5
mmol/l
108.4
105.5
2.12
18
79
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
119
896
1.39
2.64
2.6
1.8
%
1.4
1.4
0.01
104
792
(3044242) Glucose [Moles/volume] in Arterial blood
11
38
2.92
2.59
1.2
3.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
182
1470
1.31
2.55
1.4
1.3
u/ml
2.0
1.4
0.28
44
401
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
15
63
2.41
2.47
1.4
2.2
nmol/l
26.2
20.5
0.51
15
58
(1761482) Bacteria [#/volume] in Urine by Culture
28
152
1.87
2.45
7.6
3.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
76
2.26
2.45
2.5
1.7
—
—
—
0
0
(3000492) Spirometry study
87
635
1.42
2.32
2.7
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
78
2.21
2.32
3.1
2.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
635
6003
1.32
2.31
63.0
14.3
%
35.6
40.4
33.39
486
4477
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
53
2.48
2.28
1.2
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
23
3.50
2.27
11.3
3.3
u/l
226.5
198.5
—
8
23
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
165
1.79
2.22
1.1
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
9
5.58
2.21
6.0
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
151
1.82
2.18
2.2
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
14
4.31
2.15
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
625
5916
1.29
2.10
10.7
5.5
mmol/mol
40.1
39.6
0.67
598
5499
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
31
2.92
2.07
2.9
3.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
104
1328
0.75
2.02
2.8
2.9
ug/l
0.8
0.7
0.60
81
837
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
640
6094
1.29
1.93
52.1
11.9
ml/min/173m2
66.9
84.0
34.74
580
4999
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
107
1.89
1.87
2.5
1.5
—
—
—
0
0
(4010399)
64
461
1.42
1.87
2.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
54
0.00
1.85
0.0
17.3
—
1482.2
—
0
54
(1002224) Polysomnography panel
16
300
0.52
1.83
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
616
5860
1.25
1.73
5.5
4.4
mu/l
1.9
2.1
0.31
591
5362
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
90
698
1.33
1.70
1.6
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
161
0.43
1.68
1.3
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
31
2.60
1.66
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
14
3.59
1.61
2.2
2.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
15
3.35
1.52
5.8
10.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
26
162
1.63
1.51
1.4
1.9
pmol/l
192.6
222.5
0.94
26
153
(3020650) Glucose [Presence] in Urine
6
21
2.87
1.51
1.5
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
23
139
1.67
1.50
1.3
1.2
u/ml
9.1
29.4
—
5
11
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
34
227
1.52
1.49
1.4
1.8
nmol/l
37.0
39.4
0.19
34
217
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
28
2.51
1.45
1.6
1.2
ug/l
10.7
8.3
—
7
28
(3014271) Vancomycin [Susceptibility]
7
28
2.51
1.45
2.0
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
133
1.67
1.44
7.5
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
135
1129
1.24
1.42
1.4
1.3
iu/ml
20.6
33.0
1.56
52
343
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
40
2.26
1.40
2.4
1.2
ug/l
11.4
6.0
—
9
33
(4034850)
11
211
0.51
1.40
17.2
9.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
42
2.16
1.34
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
55
2.01
1.28
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
55
2.01
1.28
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
55
2.01
1.28
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
35
2.30
1.27
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
111
921
1.24
1.27
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
697
6782
1.27
1.24
56.1
12.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
677
1.27
1.23
1.5
1.5
—
—
—
0
0
(4094501)
9
167
0.53
1.20
1.6
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
234
1.43
1.12
1.5
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
30
2.35
1.12
1.7
1.3
nmol/l
126.6
145.6
—
7
30
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
97
1.66
1.07
1.6
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
122
1.57
1.03
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
63
503
1.27
1.02
1.2
1.2
—
—
—
0
0
(4024509)
9
50
1.81
0.97
3.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
27
2.23
0.93
4.0
2.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
708
6937
1.24
0.91
44.9
10.0
u/l
30.1
27.8
1.51
702
6707
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
63
1.76
0.90
1.1
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
606
6239
0.87
0.87
7.9
4.4
mmol/l
6.0
5.9
0.95
576
5717
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
47
1.71
0.81
1.3
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
196
0.66
0.74
1.5
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
24
2.09
0.74
2.8
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
40
317
1.28
0.73
1.1
1.1
titre
—
25.9
—
0
7
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
1.1
1.5
—
71.5
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
11
69
1.60
0.68
1.1
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
632
6170
1.13
0.66
7.0
3.9
mmol/l
1.6
1.3
8.63
606
5701
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
138
1.39
0.63
3.8
3.9
mg/l
28.6
25.0
—
10
86
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
73
1.51
0.56
1.3
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
12
82
1.47
0.54
3.7
2.0
%
13.7
13.1
0.82
12
82
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
68
1.48
0.47
1.3
1.1
nmol/l
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
142
0.70
0.46
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
31
1.62
0.43
2.0
1.6
—
—
—
0
0
(4281824)
8
61
1.31
0.39
1.4
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
147
0.74
0.37
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
83
755
1.11
0.37
18.3
6.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
9
70
1.29
0.36
1.7
1.2
mu/l
63.3
48.7
—
9
64
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
301
1.17
0.35
2.0
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
116
1079
1.09
0.34
1.3
1.3
u/ml
8.1
11.5
0.34
29
430
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
100
1.31
0.33
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
686
0.90
0.33
1.6
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
42
369
1.15
0.33
2.1
2.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
165
1.22
0.31
1.9
1.8
iu/l
4.8
5.7
0.11
11
51
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
172
1810
0.94
0.31
3.9
4.0
%
24.9
21.0
1.80
84
816
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
417
0.88
0.28
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
215
1.17
0.27
2.8
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
454
1.11
0.25
1.2
1.2
iu/ml
216.6
134.0
—
9
192
(3007461) Platelets [#/volume] in Blood
721
7256
0.91
0.24
91.1
19.4
e9/l
227.1
250.5
13.42
714
7075
(3027944) Amphetamines [Presence] in Urine
24
275
0.87
0.23
2.0
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
722
7264
0.91
0.23
91.1
19.6
g/l
122.3
137.1
80.04
717
7166
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
79
1.27
0.22
1.0
1.0
u/ml
0.5
4.8
—
5
29
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
191
1.16
0.22
2.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
722
7262
0.92
0.21
90.8
19.5
e9/l
7.3
6.7
2.42
716
7061
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
6.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
722
7261
0.92
0.21
90.7
19.4
e12/l
4.1
4.5
64.38
714
7065
(3008898) HLA-B27 [Presence]
25
282
0.88
0.20
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
233
1.12
0.18
2.0
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
61
1.15
0.17
1.9
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
78
0.77
0.15
1.3
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
81
773
1.05
0.14
6.0
4.3
%
30.9
31.5
0.19
73
520
(3011288) Drugs identified in Urine by Screen method
20
180
1.11
0.13
5.6
2.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
146
0.89
0.10
1.7
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
222
1.08
0.10
1.3
1.5
—
—
—
0
0
(44813793)
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
229
2253
1.02
0.09
3.9
4.6
ug/l
1.9
2.2
0.81
214
2025
(3003888) Timothy IgE Ab [Units/volume] in Serum
10
113
0.88
0.08
1.1
1.0
u/ml
9.8
6.9
—
5
61
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
649
6518
0.97
0.08
7.2
4.8
mmol/l
2.6
2.8
10.13
624
6024
(3028300) Cannabinoids [Presence] in Urine
26
276
0.94
0.07
2.8
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
80
0.87
0.07
1.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
275
0.94
0.07
2.7
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
274
0.95
0.06
2.7
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
108
0.92
0.03
1.1
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
128
0.94
0.02
1.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
77
761
1.01
0.01
1.6
2.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
95
1.05
0.00
2.1
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
105
0.95
0.00
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
105
0.95
0.00
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
125
0.96
0.00
4.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
335
1.02
0.00
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
123
0.98
0.00
1.3
1.1
u/ml
0.9
2.3
—
6
52
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
108
1.02
0.00
1.5
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
121
0.99
0.00
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
121
0.99
0.00
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
121
0.99
0.00
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
121
0.99
0.00
1.1
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
642
6422
1.00
0.00
7.3
4.3
mmol/l
4.5
4.7
6.66
620
5975
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
639
6389
1.00
0.00
7.2
4.3
mmol/l
1.3
1.4
7.60
617
5918
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
9
0.00
0.00
0.0
2.0
—
0.6
—
0
9
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
49
1.02
0.00
6.0
1.8
mmol/l
9.6
6.4
—
5
35
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
260
1.00
0.00
2.7
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
81
0.99
0.00
1.3
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: IBD_CMV – Cytomegalovirus infection, IBD co-morbidity
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).